Clinical Trial Update: Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of combining methotrexate with efalizumab (Raptiva) in psoriasis patients has completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Raptiva (efalizumab)

Snippet

Sponsor: University of California, Davis | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-06-14